Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutagenicity testing experiments with the Cobas Bact.

E Gocke, M Schüpbach

    Mutation Research
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Corrigendum to "Bacterial mutagenicity screening in the pharmaceutical industry" [Mutat. Res. 752(2) (2013) 99-118].

    Mutation research·2020
    Same author

    Stimulation of the globus pallidus internus in the treatment of Parkinson's disease: Long-term results of a monocentric cohort.

    Parkinsonism & related disorders·2019
    Same author

    Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy.

    Brain : a journal of neurology·2015
    Same author

    Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

    European journal of neurology·2013
    Same author

    Bacterial mutagenicity screening in the pharmaceutical industry.

    Mutation research·2012
    Same author

    Comprehensive assessment of the photomutagenicity, photogenotoxicity and photo(cyto)toxicity of azulene.

    Mutation research·2011
    Same journal

    Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

    Mutation research·2026
    Same journal

    Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

    Mutation research·2026
    Same journal

    IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

    Mutation research·2026
    Same journal

    Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

    Mutation research·2026
    Same journal

    The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

    Mutation research·2026
    Same journal

    E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

    Mutation research·2026
    See all related articles

    Mutagenicity testing using the Cobas Bact analyser is feasible. Reduced latency periods effectively measure strong mutagens, while fluctuation tests suit weaker ones.

    Area of Science:

    • Microbiology
    • Toxicology
    • Genetics

    Background:

    • The Cobas Bact Automatic analyser is a system for microbial analysis.
    • Assessing mutagenicity is crucial for drug development and environmental safety.
    • Traditional mutagenicity assays can be time-consuming and require specialized equipment.

    Purpose of the Study:

    • To explore the feasibility of using the Cobas Bact Automatic analyser for mutagenicity assays.
    • To determine appropriate methods for evaluating mutagenic activity with this system.
    • To investigate the influence of various experimental parameters on assay results.

    Main Methods:

    • Utilized the Cobas Bact Automatic analyser with selected model mutagens.
    • Measured the reduction in latency period as an indicator of mutagenic activity for strong mutagens.

    Related Experiment Videos

  • Employed an evaluation analogous to the fluctuation test for weaker mutagens.
  • Investigated the impact of histidine concentration, inoculum size, medium composition, and S9 concentration.

    • Main Results:

    • A reduced latency period proved to be a valid measure for strong mutagens.
    • The fluctuation test-analogous approach was more suitable for weaker mutagens.
    • The study described the influence of key variables on assay performance.
    • Adaptation to the differential growth inhibition test was also demonstrated.

    Conclusions:

    • The Cobas Bact Automatic analyser is a feasible platform for conducting mutagenicity assays.
    • Different approaches are necessary for effectively assessing strong versus weak mutagens.
    • Optimization of various parameters is important for reliable results.
    • The system shows potential for broader toxicological screening applications.